<Close Window>

   
OpenRT™ Certification Program Streamlines Interoperability Between the Electronic Medical Record and Treatment Planning Systems

IMPAC Medical Systems announces partnership with NOMOS Corporation
 
   
Mountain View, CA, November 1, 2001
IMPAC Medical Systems, Inc., the leading provider of integrated clinical and administrative management systems for cancer specialists, today announced the introduction of OpenRT™ Certification, a partnership program with treatment planning vendors including NOMOS Corp., of Sewickley, Penn.

OpenRT Certification establishes compliance, validation, deployment, and support standards for the interoperability of treatment planning systems with IMPAC’s Electronic Medical Record (EMR) and, subsequently from the EMR to the linear accelerator for treatment delivery. “The OpenRT Certification partnership confirms a mutual commitment to developing and complying with interface standards that ensure treatment plans can be seamlessly transferred, verified, and delivered, thereby providing a truly integrated clinical solution,” said Joe Jachinowski, president and chief executive officer of IMPAC.

He added, “IMPAC initiated the OpenRT Certification partnership program as a means to improve the interoperability and support of a multi-component system. The combination of IMPAC’s world leading installed base of linear accelerator Intensity Modulated Radiation Therapy (IMRT) verification systems with NOMOS’ significant IMRT treatment planning experience (over 14,000 patient plans) provides the know-how to improve overall IMRT process efficiency and the quality of care.”

“NOMOS is the pioneer of IMRT and is the recognized leader in this advanced field of radiation therapy,” said John W. Manzetti, NOMOS Corp. president and chief executive officer. “Our partnership with IMPAC will further strengthen NOMOS’ leadership position and our commitment to our customers to provide the highest possible level of service and support with completely integrated systems.”

OpenRT Certification also establishes a service partnership between the vendors to guarantee smooth implementation and Single-Point™ Customer Service. “Customers can purchase the treatment planning system and the EMR/V&R system of their choice without worrying if the systems will work together,” said Andrea Morgan, radiation oncology charting product manager for IMPAC. “By the end of 2001, customer support will be available in a single phone call; Single-Point Customer Service allows customers to call either IMPAC or NOMOS to resolve any problems that may arise.” 

About IMPAC Medical Systems, Inc.
IMPAC Medical Systems, Inc. is the leading provider of integrated clinical and administrative management systems for cancer specialists. Specializing in the development of practice management, electronic medical record, image management and decision support software, IMPAC offers practical solutions that help healthcare providers better manage the process of delivering care. IMPAC is privately held and is based in Mountain View, Calif. Founded in 1990, IMPAC currently has an installed customer base of more than 1,600 cancer centers in 45 countries worldwide, and its systems manage the daily care of more than 50,000 cancer patients. For more information about IMPAC Medical Systems’ products and services, please call 650-623-8800.

About NOMOS Corporation
NOMOS Corporation is the world’s leading supplier of planning and delivery technology for Intensity Modulated Radiation Therapy (IMRT). This precise treatment approach, which NOMOS introduced to the oncology industry in 1992, has been described as the most significant breakthrough in cancer therapy in the past 30 years and is now becoming the accepted ‘gold standard’ of care in radiation treatment. NOMOS Non-Invasive Scalpel™ IMRT allows an escalated radiation dose to be delivered to the tumor while limiting exposure and damage to nearby healthy tissue. More than 14,000 patients have safely received IMRT treatments at hospitals equipped with NOMOS’ clinically proven PEACOCK, CORVUS, and MIMiC systems throughout the world. This represents more than 95% of IMRT patients treated worldwide on FDA approved commercial systems. NOMOS also offers BAT, a unique ultrasound-based organ locator used in prostate cancer treatments, and PEREGRINE, the first commercially available treatment planning system to incorporate Monte Carlo statistical techniques to more accurately predict the radiation dose delivered to tumors and other structures within the patient’s body during a radiation treatment.

NOMOS Corporation is a privately held company located at 2591 Wexford Bayne Road, Sewickley, PA 15143 (1.800.70.NOMOS). To find out more about the Company and its treatment planning and delivery products, visit the NOMOS website at http://www.nomos.com.

Marketing Communications:
Michelle Arnold
IMPAC Medical Systems, Inc.
650-623-8883
pr@impac.com
http://www.impac.com



Link Disclaimer
 
   
   
©2003 IMPAC Medical Systems, Inc.

<Close Window>